SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Biogen Inc.
(NASDAQ : BIIB)

( )
BIIB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading BIIB News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.00%78.971.1%$778.95m
SRPTSarepta Therapeutics, Inc.
0.00%62.2427.0%$475.37m
AMGNAmgen Inc.
0.00%169.711.2%$462.12m
BIIBBiogen Inc.
0.00%310.551.1%$427.51m
MDVNMedivation, Inc.
0.05%81.481.9%$393.20m
CELGCelgene Corporation
0.00%105.830.9%$388.18m
REGNRegeneron Pharmaceuticals, Inc.
0.00%419.103.7%$315.62m
CPHDCepheid
0.00%52.695.5%$214.32m
ALXNAlexion Pharmaceuticals, Inc.
0.00%123.762.2%$173.50m
CLVSClovis Oncology, Inc.
0.00%36.3428.4%$163.46m
ILMNIllumina, Inc.
0.00%180.983.4%$139.93m
VRTXVertex Pharmaceuticals Incorporated
0.00%88.842.3%$127.85m
INCYIncyte Corporation
0.00%93.202.8%$120.53m
BMRNBioMarin Pharmaceutical Inc.
0.00%96.034.0%$114.07m
TSROTESARO, Inc.
0.00%104.4217.5%$109.74m

Company Profile

Biogen, Inc. is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded by Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.